Common side effects are mild and may include temporary injection-site irritation, headache, transient flushing, and slight appetite changes
More studies are also needed to prove if there is an actual increase in illnesses being driven by the strain
You want a choice between injectable and oral delivery, or a lower-dose option to start gently, rather than a single fixed protocol
The development of GLP-/GIP dual agonists provides a more complete scheme for the treatment of metabolic diseases, but the safety of more dual agonists or multiple agonists in clinical trials is also worthy of attention
Flag monoclonal antibodies were used for IP testing, followed by immunoblotting using anti-Flag (ab49763
Nuklearmedizin 51 (4), 111115